Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia
article
Peripheral blood mononuclear cells (PBMC) from 40 consecutive patients entering a screening program on cognitive impairment were studied in vitro with respect to their sensitivity to dexamethasone (DEX). Phytohemagglutinin-induced proliferation by PBMC from patients with senile dementia of the Alzheimer type (SDAT) was less sensitive to the inhibitory effect of DEX, compared to PBMC from patients with multi-infarct dementia (MID) and PBMC from patients with miscellaneous causes of cognitive impairment (MISC). An intermediate sensitivity was found with PBMC from patients with clinical signs of both MID and SDAT (= MIXED). These differences could not be explained by differences in the composition of the CD4+ T cell population, interleukin (IL)-2 or IL-4 production, or quantitative differences in the expression of glucocorticoid receptors as measured by flowcytometry. However, the expression of bcl-2 was higher in PBMC from SDAT patients than in cells from MID patients or from MISC patients, whereas the MIXED group showed an intermediate expression; a high bcl-2 expression correlated with a low DEX-sensitivity. These findings suggest that characteristics of PBMC reflect related changes in the central nervous system and indicate that PBMC may be a useful and accessible tool to obtain more insight into the pathogenesis of Alzheimer's disease. Chemicals/CAS: dexamethasone receptor; Dexamethasone, 50-02-2; Immunosuppressive Agents; Interleukin-2; Interleukin-4, 207137-56-2; Phytohemagglutinins; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucocorticoid
Topics
Glucocorticoid receptorClinical articleCognitive defectDrug sensitivityHuman cellLymphocyteMononuclear cellMultiinfarct dementiaScreeningAgedAged, 80 and overAlzheimer DiseaseApoptosisCells, CulturedDementia, Multi-InfarctDexamethasoneDrug ResistanceFemaleGene Expression RegulationHumansImmunosuppressive AgentsInterleukin-2Interleukin-4Lymphocyte ActivationMalePhytohemagglutininsProto-Oncogene Proteins c-bcl-2Receptors, GlucocorticoidT-Lymphocytes
TNO Identifier
233352
ISSN
08891591
Source
Brain, Behavior, and Immunity, 10(2), pp. 115-125.
Pages
115-125
Files
To receive the publication files, please send an e-mail request to TNO Repository.